Literature DB >> 9152286

Community impact of childhood varicella infections.

B P Yawn1, R A Yawn, E Lydick.   

Abstract

OBJECTIVES: To assess age-specific incidence rates, health care utilization, and lost parental work associated with varicella infection in a population-based cohort of children, and to validate parent-reported health care utilization data. STUDY
DESIGN: We conducted a telephone survey of a population-based cohort of 4557 households with children aged birth to 13 years. Medical chart abstraction was used to validate health care utilization information.
RESULTS: We report varicella incidence rates in preschool children that are 2 to 2.5 times higher than previous studies. Rates of varicella-related serious complications, hospitalizations, parental work leave, and medication use are comparable with rates reported elsewhere. However, health provider visits occurred only 0.3 to 0.5 times as frequently as estimated in other studies. One hundred percent of reported hospitalizations and serious complications and 92% of provider visits were validated to be within the study time frame through medical chart audits.
CONCLUSIONS: Parents are an accurate source of varicella-related health care utilization data. Parent-reported incidence data indicate that varicella infections are increasing in preschool children. This shift to infections in younger children may be related to the increased use of out-of-home care for infants and young children. Furthermore, the shift may after the community burden of varicella because of the observed increased parental work loss and decreased frequency of health care visits in the preschool children.

Entities:  

Mesh:

Year:  1997        PMID: 9152286     DOI: 10.1016/s0022-3476(97)80019-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

Review 1.  Varicella vaccination--a critical review of the evidence.

Authors:  S A Skull; E E Wang
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

Review 2.  Economic evaluations of varicella vaccination programmes: a review of the literature.

Authors:  Nancy Thiry; Philippe Beutels; Pierre Van Damme; Eddy Van Doorslaer
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 3.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

4.  Complications of varicella in a defined central European population.

Authors:  A Jaeggi; R P Zurbruegg; C Aebi
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

5.  Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy.

Authors:  G Kudesia; S Partridge; C P Farrington; N Soltanpoor
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

6.  Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era.

Authors:  F Dubos; B Grandbastien; V Hue; A Martinot
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

7.  Varicella vaccination in Italy : an economic evaluation of different scenarios.

Authors:  Laurent Coudeville; Alain Brunot; Carlo Giaquinto; Carlo Lucioni; Benoit Dervaux
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  The burden of severe varicella in Spain, 1995--2000 period.

Authors:  Angel Gil; Antonio González; Itziar Oyagüez; María San Martín; Pilar Carrasco
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 9.  Impact of varicella vaccine on varicella-zoster virus dynamics.

Authors:  D Scott Schmid; Aisha O Jumaan
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Time trends in pediatric hospitalizations for varicella infection are associated with climatic changes: a 22-year retrospective study in a tertiary Greek referral center.

Authors:  Elena Critselis; Panagiotis T Nastos; Kalliopi Theodoridou; Maria Theodoridou; Maria N Tsolia; Christos Hadjichristodoulou; Vassiliki Papaevangelou
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.